Cargando…
Apoptotic Cells Contribute to Melanoma Progression and This Effect is Partially Mediated by the Platelet-Activating Factor Receptor
There is evidence that the platelet-activating factor receptor (PAFR) is involved in the clearance of apoptotic cells by macrophages, and that this is associated with anti-inflammatory phenotype. Our group has previously shown that coinjection of a large number of apoptotic cells can promote tumor g...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3346991/ https://www.ncbi.nlm.nih.gov/pubmed/22577252 http://dx.doi.org/10.1155/2012/610371 |
_version_ | 1782232258109767680 |
---|---|
author | Bachi, André Luis Lacerda dos Santos, Lívia Caires Nonogaki, Suely Jancar, Sônia Jasiulionis, Miriam Galvonas |
author_facet | Bachi, André Luis Lacerda dos Santos, Lívia Caires Nonogaki, Suely Jancar, Sônia Jasiulionis, Miriam Galvonas |
author_sort | Bachi, André Luis Lacerda |
collection | PubMed |
description | There is evidence that the platelet-activating factor receptor (PAFR) is involved in the clearance of apoptotic cells by macrophages, and that this is associated with anti-inflammatory phenotype. Our group has previously shown that coinjection of a large number of apoptotic cells can promote tumor growth from a subtumorigenic dose of melanoma cells. Here, we studied the involvement of the PAFR in the tumor growth promoting effect of apoptotic cells. A sub-tumorigenic dose of melanoma cells (Tm1) was coinjected with apoptotic Tm1 cells, subcutaneously in the flank of C57Bl/6 mice, and the volume was monitored for 30 days. Animals received the PAFR antagonists, WEB2170 or PCA4248 (5 mg/kg body weight) or vehicle, by peritumoral daily injection for 5 days. Results showed that PAFR antagonists significantly inhibited the tumor growth induced by the coinjection of a sub-tumorigenic dose of melanoma cells together with apoptotic cells. This was accompanied by inhibition of early neutrophil and macrophage infiltration. Addition of (platelet-activating factor) to this system has no significant effect. PAFR antagonists did not affect the promoting effect of carrageenan. We suggest that the recognition of apoptotic cells by phagocytes leads to activation of PAFR pathways, resulting in a microenvironment response favorable to melanoma growth. |
format | Online Article Text |
id | pubmed-3346991 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-33469912012-05-10 Apoptotic Cells Contribute to Melanoma Progression and This Effect is Partially Mediated by the Platelet-Activating Factor Receptor Bachi, André Luis Lacerda dos Santos, Lívia Caires Nonogaki, Suely Jancar, Sônia Jasiulionis, Miriam Galvonas Mediators Inflamm Research Article There is evidence that the platelet-activating factor receptor (PAFR) is involved in the clearance of apoptotic cells by macrophages, and that this is associated with anti-inflammatory phenotype. Our group has previously shown that coinjection of a large number of apoptotic cells can promote tumor growth from a subtumorigenic dose of melanoma cells. Here, we studied the involvement of the PAFR in the tumor growth promoting effect of apoptotic cells. A sub-tumorigenic dose of melanoma cells (Tm1) was coinjected with apoptotic Tm1 cells, subcutaneously in the flank of C57Bl/6 mice, and the volume was monitored for 30 days. Animals received the PAFR antagonists, WEB2170 or PCA4248 (5 mg/kg body weight) or vehicle, by peritumoral daily injection for 5 days. Results showed that PAFR antagonists significantly inhibited the tumor growth induced by the coinjection of a sub-tumorigenic dose of melanoma cells together with apoptotic cells. This was accompanied by inhibition of early neutrophil and macrophage infiltration. Addition of (platelet-activating factor) to this system has no significant effect. PAFR antagonists did not affect the promoting effect of carrageenan. We suggest that the recognition of apoptotic cells by phagocytes leads to activation of PAFR pathways, resulting in a microenvironment response favorable to melanoma growth. Hindawi Publishing Corporation 2012 2012-04-22 /pmc/articles/PMC3346991/ /pubmed/22577252 http://dx.doi.org/10.1155/2012/610371 Text en Copyright © 2012 André Luis Lacerda Bachi et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Bachi, André Luis Lacerda dos Santos, Lívia Caires Nonogaki, Suely Jancar, Sônia Jasiulionis, Miriam Galvonas Apoptotic Cells Contribute to Melanoma Progression and This Effect is Partially Mediated by the Platelet-Activating Factor Receptor |
title | Apoptotic Cells Contribute to Melanoma Progression and This Effect is Partially Mediated by the Platelet-Activating Factor Receptor |
title_full | Apoptotic Cells Contribute to Melanoma Progression and This Effect is Partially Mediated by the Platelet-Activating Factor Receptor |
title_fullStr | Apoptotic Cells Contribute to Melanoma Progression and This Effect is Partially Mediated by the Platelet-Activating Factor Receptor |
title_full_unstemmed | Apoptotic Cells Contribute to Melanoma Progression and This Effect is Partially Mediated by the Platelet-Activating Factor Receptor |
title_short | Apoptotic Cells Contribute to Melanoma Progression and This Effect is Partially Mediated by the Platelet-Activating Factor Receptor |
title_sort | apoptotic cells contribute to melanoma progression and this effect is partially mediated by the platelet-activating factor receptor |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3346991/ https://www.ncbi.nlm.nih.gov/pubmed/22577252 http://dx.doi.org/10.1155/2012/610371 |
work_keys_str_mv | AT bachiandreluislacerda apoptoticcellscontributetomelanomaprogressionandthiseffectispartiallymediatedbytheplateletactivatingfactorreceptor AT dossantosliviacaires apoptoticcellscontributetomelanomaprogressionandthiseffectispartiallymediatedbytheplateletactivatingfactorreceptor AT nonogakisuely apoptoticcellscontributetomelanomaprogressionandthiseffectispartiallymediatedbytheplateletactivatingfactorreceptor AT jancarsonia apoptoticcellscontributetomelanomaprogressionandthiseffectispartiallymediatedbytheplateletactivatingfactorreceptor AT jasiulionismiriamgalvonas apoptoticcellscontributetomelanomaprogressionandthiseffectispartiallymediatedbytheplateletactivatingfactorreceptor |